Rbf Capital »

Zentalis Pharmaceuticals shares owned by Rbf Capital

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Rbf Capital from 13F filings

Historical chart of Rbf Capital investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Rbf Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Rbf Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $121k 80k 1.51
2025-06-30 $93k 80k 1.16

More positions owned by Rbf Capital

Morgan Stanley Com New Put Option (MS)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Applovin Corp Com Cl A (APP)
Meta Platforms Cl A (META)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Bank of America Corporation (BAC)
Danaos Corporation SHS (DAC)
Mastercard Incorporated Cl A (MA)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Visa Com Cl A (V)
Hca Holdings (HCA)
Builders FirstSource (BLDR)
Apple (AAPL)
Fair Isaac Corporation (FICO)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Rbf Capital

Top funds holding Zentalis Pharmaceuticals

Matrix Capital Management Company
Vanguard Group
Acadian Asset Management
Renaissance Technologies
Citadel Advisors
Tang Capital Management
Two Sigma Advisers
D. E. Shaw & Co
Two Sigma Investments
Decheng Capital
BlackRock
Balyasny Asset Management
Morgan Stanley
GSA Capital Partners
PRIMECAP Management Company

View all funds holding Zentalis Pharmaceuticals